Global Cystic Fibrosis (CF) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Jan, 2019
|
Report ID: 28883
|
133
|
Pharmaceuticals and Healthcare
Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.
Scope of the Report:
This report focuses on the Cystic Fibrosis (CF) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Cystic Fibrosis (CF) Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Vertex Pharmaceuticals Incorporated
Gilead
AbbVie, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co. Inc.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
Market Segment by Applications, can be divided into
Oral drugs
Inhaled drugs
There are 15 Chapters to deeply display the global Cystic Fibrosis (CF) Therapeutics market.
Chapter 1, to describe Cystic Fibrosis (CF) Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cystic Fibrosis (CF) Therapeutics, with sales, revenue, and price of Cystic Fibrosis (CF) Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cystic Fibrosis (CF) Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cystic Fibrosis (CF) Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cystic Fibrosis (CF) Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Cystic Fibrosis (CF) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Cystic Fibrosis (CF) Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Vertex Pharmaceuticals Incorporated
Gilead
AbbVie, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co. Inc.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
Market Segment by Applications, can be divided into
Oral drugs
Inhaled drugs
There are 15 Chapters to deeply display the global Cystic Fibrosis (CF) Therapeutics market.
Chapter 1, to describe Cystic Fibrosis (CF) Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cystic Fibrosis (CF) Therapeutics, with sales, revenue, and price of Cystic Fibrosis (CF) Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cystic Fibrosis (CF) Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cystic Fibrosis (CF) Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cystic Fibrosis (CF) Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cystic Fibrosis (CF) Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Pancreatic enzyme supplements
1.2.2 Mucolytics
1.2.3 Bronchodilators
1.2.4 CFTR modulators
1.3 Market Analysis by Applications
1.3.1 Oral drugs
1.3.2 Inhaled drugs
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Vertex Pharmaceuticals Incorporated
2.1.1 Business Overview
2.1.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gilead
2.2.1 Business Overview
2.2.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AbbVie, Inc.
2.3.1 Business Overview
2.3.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche Ltd
2.5.1 Business Overview
2.5.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Alaxia
2.6.1 Business Overview
2.6.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck & Co. Inc.
2.7.1 Business Overview
2.7.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 AIT (Advanced Inhalation Therapies)
2.8.1 Business Overview
2.8.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 ALLERGAN
2.9.1 Business Overview
2.9.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Teva Pharmaceutical Industries Ltd
2.11.1 Business Overview
2.11.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alcresta
2.12.1 Business Overview
2.12.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cystic Fibrosis (CF) Therapeutics Market Analysis by Regions
4.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5 North America Cystic Fibrosis (CF) Therapeutics by Countries
5.1 North America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Cystic Fibrosis (CF) Therapeutics by Countries
6.1 Europe Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cystic Fibrosis (CF) Therapeutics by Countries
7.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8 South America Cystic Fibrosis (CF) Therapeutics by Countries
8.1 South America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cystic Fibrosis (CF) Therapeutics by Countries
9.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
10 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Type
10.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Pancreatic enzyme supplements Sales Growth and Price
10.2.1 Global Pancreatic enzyme supplements Sales Growth (2013-2018)
10.2.2 Global Pancreatic enzyme supplements Price (2013-2018)
10.3 Mucolytics Sales Growth and Price
10.3.1 Global Mucolytics Sales Growth (2013-2018)
10.3.2 Global Mucolytics Price (2013-2018)
10.4 Bronchodilators Sales Growth and Price
10.4.1 Global Bronchodilators Sales Growth (2013-2018)
10.4.2 Global Bronchodilators Price (2013-2018)
10.5 CFTR modulators Sales Growth and Price
10.5.1 Global CFTR modulators Sales Growth (2013-2018)
10.5.2 Global CFTR modulators Price (2013-2018)
11 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Application
11.1 Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Application (2013-2018)
11.2 Oral drugs Sales Growth (2013-2018)
11.3 Inhaled drugs Sales Growth (2013-2018)
12 Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Cystic Fibrosis (CF) Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.4 South America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.3 Cystic Fibrosis (CF) Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Cystic Fibrosis (CF) Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
1 Market Overview
1.1 Cystic Fibrosis (CF) Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Pancreatic enzyme supplements
1.2.2 Mucolytics
1.2.3 Bronchodilators
1.2.4 CFTR modulators
1.3 Market Analysis by Applications
1.3.1 Oral drugs
1.3.2 Inhaled drugs
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Vertex Pharmaceuticals Incorporated
2.1.1 Business Overview
2.1.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gilead
2.2.1 Business Overview
2.2.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AbbVie, Inc.
2.3.1 Business Overview
2.3.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche Ltd
2.5.1 Business Overview
2.5.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Alaxia
2.6.1 Business Overview
2.6.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck & Co. Inc.
2.7.1 Business Overview
2.7.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 AIT (Advanced Inhalation Therapies)
2.8.1 Business Overview
2.8.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 ALLERGAN
2.9.1 Business Overview
2.9.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Teva Pharmaceutical Industries Ltd
2.11.1 Business Overview
2.11.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alcresta
2.12.1 Business Overview
2.12.2 Cystic Fibrosis (CF) Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cystic Fibrosis (CF) Therapeutics Market Analysis by Regions
4.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5 North America Cystic Fibrosis (CF) Therapeutics by Countries
5.1 North America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Cystic Fibrosis (CF) Therapeutics by Countries
6.1 Europe Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cystic Fibrosis (CF) Therapeutics by Countries
7.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8 South America Cystic Fibrosis (CF) Therapeutics by Countries
8.1 South America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cystic Fibrosis (CF) Therapeutics by Countries
9.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
10 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Type
10.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Pancreatic enzyme supplements Sales Growth and Price
10.2.1 Global Pancreatic enzyme supplements Sales Growth (2013-2018)
10.2.2 Global Pancreatic enzyme supplements Price (2013-2018)
10.3 Mucolytics Sales Growth and Price
10.3.1 Global Mucolytics Sales Growth (2013-2018)
10.3.2 Global Mucolytics Price (2013-2018)
10.4 Bronchodilators Sales Growth and Price
10.4.1 Global Bronchodilators Sales Growth (2013-2018)
10.4.2 Global Bronchodilators Price (2013-2018)
10.5 CFTR modulators Sales Growth and Price
10.5.1 Global CFTR modulators Sales Growth (2013-2018)
10.5.2 Global CFTR modulators Price (2013-2018)
11 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Application
11.1 Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Application (2013-2018)
11.2 Oral drugs Sales Growth (2013-2018)
11.3 Inhaled drugs Sales Growth (2013-2018)
12 Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Cystic Fibrosis (CF) Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.4 South America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.3 Cystic Fibrosis (CF) Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Cystic Fibrosis (CF) Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cystic Fibrosis (CF) Therapeutics Picture
Table Product Specifications of Cystic Fibrosis (CF) Therapeutics
Figure Global Sales Market Share of Cystic Fibrosis (CF) Therapeutics by Types in 2017
Table Cystic Fibrosis (CF) Therapeutics Types for Major Manufacturers
Figure Pancreatic enzyme supplements Picture
Figure Mucolytics Picture
Figure Bronchodilators Picture
Figure CFTR modulators Picture
Figure Cystic Fibrosis (CF) Therapeutics Sales Market Share by Applications in 2017
Figure Oral drugs Picture
Figure Inhaled drugs Picture
Figure United States Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Vertex Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Type and Applications
Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Type and Applications
Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alaxia Basic Information, Manufacturing Base and Competitors
Table Alaxia Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AIT (Advanced Inhalation Therapies) Basic Information, Manufacturing Base and Competitors
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Type and Applications
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ALLERGAN Basic Information, Manufacturing Base and Competitors
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Type and Applications
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Type and Applications
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alcresta Basic Information, Manufacturing Base and Competitors
Table Alcresta Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Cystic Fibrosis (CF) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Cystic Fibrosis (CF) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Regions (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Regions (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Regions in 2013
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Regions in 2017
Figure North America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2013
Figure North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017
Table North America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Table North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2013
Figure North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure United States Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table Europe Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure France Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries 2017
Figure China Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure India Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table South America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017
Table South America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Table South America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Type (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Share by Type (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Type (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Type (2013-2018)
Figure Global Pancreatic enzyme supplements Sales Growth (2013-2018)
Figure Global Pancreatic enzyme supplements Price (2013-2018)
Figure Global Mucolytics Sales Growth (2013-2018)
Figure Global Mucolytics Price (2013-2018)
Figure Global Bronchodilators Sales Growth (2013-2018)
Figure Global Bronchodilators Price (2013-2018)
Figure Global CFTR modulators Sales Growth (2013-2018)
Figure Global CFTR modulators Price (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Application (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Share by Application (2013-2018)
Figure Global Inhaled drugs Sales Growth (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure South America Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Cystic Fibrosis (CF) Therapeutics Picture
Table Product Specifications of Cystic Fibrosis (CF) Therapeutics
Figure Global Sales Market Share of Cystic Fibrosis (CF) Therapeutics by Types in 2017
Table Cystic Fibrosis (CF) Therapeutics Types for Major Manufacturers
Figure Pancreatic enzyme supplements Picture
Figure Mucolytics Picture
Figure Bronchodilators Picture
Figure CFTR modulators Picture
Figure Cystic Fibrosis (CF) Therapeutics Sales Market Share by Applications in 2017
Figure Oral drugs Picture
Figure Inhaled drugs Picture
Figure United States Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Vertex Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Type and Applications
Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Type and Applications
Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alaxia Basic Information, Manufacturing Base and Competitors
Table Alaxia Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AIT (Advanced Inhalation Therapies) Basic Information, Manufacturing Base and Competitors
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Type and Applications
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ALLERGAN Basic Information, Manufacturing Base and Competitors
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Type and Applications
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Type and Applications
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alcresta Basic Information, Manufacturing Base and Competitors
Table Alcresta Cystic Fibrosis (CF) Therapeutics Type and Applications
Table Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Cystic Fibrosis (CF) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Cystic Fibrosis (CF) Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Regions (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Regions (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Regions in 2013
Figure Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Regions in 2017
Figure North America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2013
Figure North America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017
Table North America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Table North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2013
Figure North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure United States Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table Europe Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure France Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries 2017
Figure China Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure India Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table South America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017
Table South America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Table South America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Type (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Share by Type (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue by Type (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Type (2013-2018)
Figure Global Pancreatic enzyme supplements Sales Growth (2013-2018)
Figure Global Pancreatic enzyme supplements Price (2013-2018)
Figure Global Mucolytics Sales Growth (2013-2018)
Figure Global Mucolytics Price (2013-2018)
Figure Global Bronchodilators Sales Growth (2013-2018)
Figure Global Bronchodilators Price (2013-2018)
Figure Global CFTR modulators Sales Growth (2013-2018)
Figure Global CFTR modulators Price (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales by Application (2013-2018)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Share by Application (2013-2018)
Figure Global Inhaled drugs Sales Growth (2013-2018)
Figure Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure South America Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application (2018-2023)
Table Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
